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Abstract
Background: Practicing activities improves recovery after stroke, but many people in hospital do little activity.
Feedback on activity using an accelerometer is a potential method to increase activity in hospital inpatients. This
study’s goal is to investigate the effect of feedback, enabled by a Smart watch, on daily physical activity levels
during inpatient stroke rehabilitation and the short-term effects on simple functional activities, primarily mobility.
Methods/design: A randomized controlled trial will be undertaken within the stroke rehabilitation wards of the
Second Affiliated hospital of Anhui University of Traditional Chinese Medicine, Hefei, China. The study participants
will be stroke survivors who meet inclusion criteria for the study, primarily: able to participate, no more than
4 months after stroke and walking independently before stroke. Participants will all receive standard local
rehabilitation and will be randomly assigned either to receive regular feedback about activity levels, relative to a
daily goal tailored by the smart watch over five time periods throughout a working day, or to no feedback, but still
wearing the Smart watch. The intervention will last up to 3 weeks, ending sooner if discharged. The data to be
collected in all participants include measures of daily activity (Smart watch measure); mobility (Rivermead Mobility
Index and 10-metre walking time); independence in personal care (Barthel Activities of Daily Living (ADL) Index);
overall activities (the World Health Organization (WHO) Disability Assessment Scale, 12-item version); and quality of
life (the Euro-Qol 5L5D). Data will be collected by assessors blinded to allocation of the intervention at baseline,
3 weeks or at discharge (whichever is the sooner); and a reduced data set will be collected at 12 weeks by
telephone interview. The primary outcome will be change in daily accelerometer activity scores. Secondary
outcomes are compliance and adherence to wearing the watch, and changes in mobility, independence in
personal care activities, and health-related quality of life.
Discussion: This project is being implemented in a large city hospital with limited resources and limited research
experience. There has been a pilot feasibility study using the Smart watch, which highlighted some areas needing
change and these are incorporated in this protocol.
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Background
After stroke, practicing an activity and being active helps
increase the speed and/or extent of recovery [1] but it is
well-established that most inpatients in stroke rehabilita-
tion settings have low levels of activity [2–4]. Increasing
patients’ self-generated activity is possible through
reorganizing care [5, 6] and could potentially play an
important role in increasing independence.
Another way to increase activity and therefore to im-
prove recovery of independence is to provide tailored
feedback on activity and on progress towards goals. This
could increase motivation, self-efficacy, and self-generated
activity. Accelerometers can be used to record activity [2],
and they can also be used to provide feedback; use of daily
data by therapists can increase time spent walking [7].
There are several studies investigating the effect of feed-
back about physical activity from accelerometers to indi-
viduals. Some show no effect [8, 9] but some show
beneficial effects [7, 10]. Benefits seem more likely if feed-
back is supported by other motivational support [11].
Most of these studies were published after the design of
this project; there are many other study protocols pub-
lished but not yet completed.
The primary objective of this study is to determine
whether patient feedback about the amount of activity
undertaken compared to their activity the previous day,
provided at fixed time points during the day, will increase
patient activity. We hypothesise that, compared to a con-
trol group who do not receive feedback from a Smart
watch, those who receive feedback on daily activity will
have increased physical activity levels, as measured by the
activity scores, with no harms. We also hypothesize that
this increased activity during inpatient stroke rehabilita-
tion will result in improved mobility, and possibly cogni-
tion, arm function, independence in daily activities, and
health-related quality of life. A third objective is to investi-
gate the feasibility of setting up large-scale trials in a
research-naïve setting. This protocol follows an initial pilot
and feasibility study. (Lawrie S, Gong Y, Steins D, Xia Z,
Esser P, Sun S, Li F, Amor J, James C, Izadi H, Chao Y,
Wade DT, Dawes H: Augmented Feedback of Daily Activity
on Physical Activity Levels after Acute Stroke: a pilot
randomised controlled feasibility study, in preparation).
Methods
This study was originally registered with ClinicalTrials.gov
on 30 September 2015 (NCT02587585). The original
registration was for both the initial pilot and feasibility
phase, now completed (submitted for publication), and
this phase, which has been adjusted from the original
in the light of the pilot phase. The trial was also
registered with the Chinese Clinical Trial Registry
(http://www.chictr.org.cn/showprojen.aspx?proj=12091)
on 8 August 2015 (ChiCTR-IOR-15007179). As part of this
registration it was also considered by the Chinese National
Ethics committee and given a favourable opinion; the certifi-
cate is within the registration details, and has reference num-
ber ChiECRCT-20150034 (see http://www.chictr.org.cn/
uploads/file/20151009090354.JPG). All research will be in
compliance with the Helsinki Declarations and the
Research Governance Framework for Health and Social
Care. Informed consent will be obtained from all partici-
pants before involvement in the study.
The trial sponsor is The Second Affiliated Hospital of
Anhui University of Traditional Chinese Medicine,
Hefei, Anhui Province, China. The public contact is
Zhidao Xia, the scientific contact is Derick Wade. This
protocol (6 February 2017) has been amended from the
original registered protocol (30 September 2015) in the
light of the feasibility study; data will not be collected at
6 months because this is not practical. This study started
after the feasibility phase, on 20 April 2016 and by 6
February 2017 (date of original submission) had re-
cruited 88 of a target of 200 people.
The study team (ZX, HD, YD) confer by video-phone
conference every 2–4 weeks. The local committee is
the Smart Watch Activity Feedback Trial Committee
(SWAFT), whose members are given in the title page.
They meet to resolve any local practical problems.
There is no additional data monitoring committee be-
cause harmful effects are considered improbable and
the study will be short. The primary specific funding
body did not undertake an external peer review of the
protocol.
Design
This study is an efficacy, single-blind, randomized
controlled trial with the assessor blinded to the group
allocation. Participants cannot be blinded to group
allocation and ward staff will not be. The intervention
being studied is for all patients to wear a Smart watch
throughout a normal working day (0800–1700 hours)
from Monday to Friday for up to 15 days. They will be
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randomly assigned, using concealed allocation, to one of
two groups where the watch gives:
 Feedback on amount of physical activity
(movement) undertaken, two hourly for the first
8 hours and then for the last 1–2 hours (dependent
on the battery life) or
 No feedback about the physical activity levels during
a 3-week intervention period.
All other interventions (medication, physical therapy)
will be kept to their normal routine.
The flow of the study is shown in Fig. 1. Patients will be
recruited from all admissions to the rehabilitation wards
in the Second Affiliated Hospital of Anhui University of
Traditional Chinese Medicine, a large urban hospital.
Only patients admitted for rehabilitation after a recent
stroke will be approached. The procedure used needs to
be compatible with normal clinical practice.
Two questions will be used for initial screening:
1. Can the patient follow a two-stage command, judged
clinically?
2. Was the patient walking without help from another
person before this stroke?
All subjects who answer “yes” to both questions are
eligible and will be entered into the consent and selec-
tion process. An investigator will explain the consent
form, and allow the person ample time to read through
the consent form and ask questions. If they agree, they
will acknowledge consent by signing the form. All poten-
tial participants will have up to 24 hours to decide
whether they want to partake in this study. All actual
participants will have given informed consent, signed by
them or by an independent witness if necessary, before
they are registered.
Patients will be eligible if they:
a. Are aged 40–75 years
b. Had onset of stroke less than 4 months ago
c. Are being admitted for rehabilitation for the
first time
d. Were able to walk at least 10 m prior to stroke,
without help of another person; use of
equipment allowed
e. Have sufficient cognition to participate in the study
and testing procedures (clinically judged, because
there are no valid short cognitive measures to assess
ability to consent and participate)
f. Can follow a 2-stage command (e.g. pick up an
object, put it on the table)
g. Have sufficient visual function to see the watch
feedback (clinically judged)
h. Have the capacity to consent and then give consent
to participate in the study
Entry may be delayed after admission if a person
satisfied all other criteria but was not yet able to follow a
2-stage command. In this case, 3-day follow up will be
performed, and the patient will be eligible if they then
meet that criterion. This was added to allow for patients
transferred within 1 or 2 weeks of a stroke, and patients
who become confused by the move from another hos-
pital. Patients admitted a second time within the study
period will be excluded.
Participants will be randomly assigned to one of two
groups: (1) feedback of activity levels; or (2) no feedback
of activity levels (i.e. control group). A block stratified
randomization approach with two strata will be used,
based on walking speed at the time of recruitment. A
threshold of 0.42 m/s [12] will be used to define two
groups: slow walkers (< 0.42 m/s) unlikely to walk in the
community, and moderate-fast walkers (> 0.42 m/s).
People unable to walk at the time of recruitment will be
classified as slow walkers. The block size will be 5.
Once recruited, the recruiting doctor will inform the
research office personnel, who are not blinded, and they
will then undertake allocation. Allocation will be per-
formed using a computer program in Microsoft Excel to
Fig. 1 Consolidated Standards of Reporting Trials (CONSORT)-style
flow diagram
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allocate groups and generate numbers for each stratum
(slow walkers or not slow walkers); the allocation will be
made by the research office staff after registration. The
research office will then notify the ward about the
patient’s allocation by telephone. The researchers who
will be performing all assessments will remain blinded
to group assignment throughout the study.
The participants’ rehabilitation programmes will con-
tinue as normal, with no change in relation to this study.
Therapists will not specifically be informed about a
participant’s group, but may learn this. However thera-
pists will not specifically encourage use of the feedback
(or the opposite).
Intervention - the China Monitoring (CHMON) feedback
system
The CHMON system utilized for the project is a ZGPAX
S8 [13]. The S8 is a full android Smart watch encapsu-
lated in a wrist-wearable unit. As such it is capable of
running apps written for it and operating in a stand-
alone manner. The hardware specifications for the
ZGPAX S8 are shown in Table 1.
The CHMON system is used both as a data gathering
platform and as a feedback device to the patient in the ex-
perimental group (Fig. 2). The patient wears the device for
9 hours a day. In the intervention group, the watch will
divide elapsed time into four periods of 2 hours, and one
of 1 hour. In the control group the activity level is simply
recorded, and no further processing occurs.
In the intervention group the data from the first day is
used to establish baseline activity levels for each epoch.
Daily activity is calculated in 2-hour periods (with one
1-hour period). Each day, the watch calculates a goal
for the patient for each period, the goal being 5%
higher than the activity recorded in the same period
24 hours earlier.
To gather data from the ZGPAX S8 a custom app was
written, based around work by Amor et al. [14] and
Ahanathapillai et al. [15], which has been used in previ-
ous work looking at physical activity monitoring, among
other parameters, in older people. The app records data
from the ZGPAX S8 tri-axial accelerometer and pro-
cesses it to extract a measure of physical activity, the ac-
tivity score [16]. A slightly modified activity score has
been shown to correlate well with energy expenditure,
measured in kilocalories per minute (kcal/min), in re-
sults obtained from a comparison of activity score
against energy expenditure obtained from whole-room
calorimetry [17].
Calculation of the activity score [16] and modification
of the activity score [14] have been fully described previ-
ously; only brief details are repeated here. Raw acceler-
ation data are recorded from the CHMON system in
three orthogonal axes, X, Y and Z, at 16.6 Hz using a
30-sec on, 120-sec off interval-sampling regime. The
30-sec-on period is subsequently referred to as an epoch.
Sampling was carried out in this manner to preserve
battery life on the device whilst endeavoring to capture as
much of the patient’s activity as possible. The intention is
to compare relative levels of activity from day to day, over
the treatment period, and between groups. It is not
intended to measure actual activity. Using an accelerom-
eter located on the wrist of the unaffected arm, and a
sampling procedure covering 20% of the time should allow
this without risking systematic bias.
Subsequent data processing of the raw data happens
within the watch using inbuilt software in three stages.
In the first stage, baseline smoothing is used to remove
Table 1 Hardware specifications for the ZGPAX S8 android
Smart watch
Hardware specification
Size 58 × 42.5 × 13 mm
Weight 67 g
Screen 40 mm capacitive touchscreen
Battery 3.7 V/470mAh Li-ion (rechargeable)
CPU MTK6572 Dual Core 1.2 GHz
Memory 12 GB total
RAM 512 MB
Android version 4.4.2
Sensors GPS, accelerometer
Connectivity WiFi, Bluetooth, 2G, 3G
Waterproof No
CPU central processing unit, RAM random access memory
Fig. 2 The watch face: blue clock icon showing current 2-hour window
and red-green bars showing activity feedback (one group only)
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some of the noise from the signal that is caused by
analogue to digital conversion. This has the effect of sig-
nificantly reducing noise when the CHMON is station-
ary and where noise therefore is the overriding
component in the signal. This is performed on all three
axes independently.
In the second stage, the root mean squared combin-
ation of the X, Y and Z axes is calculated. The effect of
gravity on the accelerometer data (causing a continuous
1 g reading towards the ground) is removed by subtract-
ing the mean of the signal with a 3-sec sliding window.
From these data, an assessment of the CHMON worn-
state, either worn or not worn, is carried out, which
looks to see if the data show any movement and if they
do not, the CHMON system is assumed to be not worn
and no further processing is applied.
In the final stage, the mean value of the data over the
epoch is calculated and adjusted to increase the variance
at the lower end of the value range. The value is left
unrounded and is used as the activity score [12].
Activity score data from each epoch are added to a
tally of activity score for the current time period and
these data are used, in the feedback group only, both to
provide feedback to and to set goals for the patient.
Goals for a day are set to be 5% more in each period that
the sum activity score obtained in the corresponding
period the previous day.
There are two parts to the user interface; the clock
icon and the activity tracker (Fig. 3). The clock icon
shows the participant which time period they are cur-
rently in. The activity tracker shows how close the pa-
tient is to meeting their activity target for the day. All
patients will see the clock icon.
Each bar of the activity tracker fills as the patient
meets a particular percentage of their target activity in
the particular epoch. These are set to 1/3, 2/3 and 3/3 of
the target such that the next bar (from red to green) will
light up when the patient passes these markers. The full
green bar lights up when the patient has met or
exceeded their target. (See Fig. 4) The feedback page is
only shown to the feedback group during the active time
periods. At all other times, and at all times for the non-
feedback group, the screen simply shows a larger version
of the clock icon.
The first day will serve as a baseline measure, in which
none of the participants will receive feedback on their
activity levels. Thereafter each morning, an investigator
will provide the participant with a Smart watch to be worn
on the unaffected side and will remind the participant
about the purpose of the watch; either to record activity
(control group) or to provide feedback on activity
(intervention group). Each evening an investigator will see
the person, check that there have been no unexpected
events or problems such as falls, or other adverse events,
and then take the watch away so that data can be down-
loaded, and the watch recharged for use the next day.
In order to ensure that all researchers administer the
intervention in a consistent manner, we will host a series
of in-service training sessions on the use of the Smart
watch. These in-services will focus specifically on the
setup, data storage, and output from the CHMON system.
The control group will wear the same watch, and be
seen each day by the researcher to collect the watch. In
this way we will control for additional attention, and to
an extent for any expectations generated by involvement
in a trial and wearing a watch.
Data collected
The assessment schedule is shown in Fig. 4. The re-
searchers will collect the following demographic and
medical information from clinical notes on admission to
rehabilitation: age, sex, height, weight and dates of
stroke onset and admission. Moreover at each contact
the research doctors will ask the patient about any prob-
lems with the watch, and will look out for any observ-
able adverse effects such as a skin rash. The primary
data will be the daily activity counts generated by the
Smart watch and downloaded daily by the researcher.
Fig. 3 Progression of activity completion (top row) and time epoch (below) on the watch face. Note, only the intervention group will see
activity feedback
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Data will be collected by investigators trained in the
use of the measures, using Chinese versions of the mea-
sures where relevant. The investigator will not know
which group the participant is in. The following clinical
data will be collected at baseline, end of intervention or
at 3 weeks, and some will be collected by phone at
3 months (see Fig. 4):
a. The Barthel Activities of Daily Living (ADL) Index
(BI) [18], a 10-item scale that assesses the ability of an
individual with a neuromuscular or musculoskeletal
disorder to care for him/herself.
b. The Rivermead Mobility Index (RMI) [19], a 15-item
rating scale (14-self-reported items and 1 direct
observation item) that assesses functional mobility
following stroke (e.g. gait, balance, and transfers).
c. The Montreal Cognitive Assessment (MOCA) [20]
(Mandarin version) [21, 22], a 16-item scale that
assesses the cognitive abilities designed to detect
mild cognitive dysfunction.
d. The Fatigue Severity Scale (FSS) [23–25], a 9-item
scale that measures the severity of fatigue and its
effect on a person’s activities and lifestyle.
e. The World Health Organization 12 item Disability
Assessment Schedule (WHODAS) [26], a
questionnaire that assesses six domains of
day-to-day functioning and provides an overall
disability score based on this.
f. The Euro-QOL (EQ-5D-3L) [27, 28], a questionnaire
that provides a simple measure of health for clinical
and economic appraisal. This questionnaire measures
the dimension of mobility, self-care, usual activities,
pain/discomfort and anxiety/depression.
g. Grip strength [29] provides a quantitative and
objective measure of isometric muscular strength of
the hand and forearm.
h. The 10-m walk test (10MWT) [30] assesses walking
speed over 10 m.
i. Spatio-temporal gait features at self-selected walking
speed measured during a 10MWT using an inertial
sensor (LPMS-B, Life Performance Research, Japan)
on the lower trunk. Participants will be instructed to
walk twice along a 10-m walkway at their normal pace
with a walking aid or the support of a researcher.
Walking speed, cadence, step length and symmetry of
spatio-temporal measures will be calculated [31].
The outcome measure on which the intervention study
is powered is change in activity scores as measured by a
tri-axial accelerometer from a Smart watch.
Patients with stroke tend to be discharged from in-
patient rehabilitation at the Second Affiliated Hospital of
Anhui University of Traditional Chinese Medicine after
2–3 weeks. Therefore, the length of the inpatient interven-
tion phase will vary between participants but will be no
more than 3 weeks. Activity score (i.e. counts) are sum-
marised at five time points (i.e. at 2-hour increments)
throughout the day. Summary analysis, from each time
point and from the whole day will be used in the analysis.
Data handling and analysis
The data will be collected by researchers on the ward using
prepared forms. The forms will be given to the research of-
fice where they will be entered into an Excel spreadsheet
database. The paper forms will be stored in secure, locked
files. De-identified and encrypted data will then be sent elec-
tronically on a weekly basis to Oxford Brookes University
where they will be checked (a) for obvious errors (e.g. data
outside the possible range) and (b) for missing data. If
needed, the research centre in Hefei will be contacted to
clarify apparent errors and to confirm whether missing
data are truly absent. The electronic data will be stored in
a secure database at Oxford Brookes University, but all
investigators will have free access to all electronic data.
Fig. 4 Standard protocol items: recommendation for interventional
trials (SPIRIT) figure of study timing and activities. ADL, activities of
daily living; WHO, World Health Organization
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The following measures will be compared between the
two intervention groups: Barthel ADL index, Rivermead
Mobility Index, Fatigue Severity Scale, Montreal Cognitive
Assessment, WHO Disability Assessment Scale, EuroQol
5D-5L, and length of inpatient stay. Data will be analysed
based on the intention-to-treat principle.
Descriptive statistics will be calculated for demo-
graphic characteristics and compliance data. The
independent samples or the chi-square (X2) test will be
used to assess differences between group means and
frequencies at baseline, the test being chosen according
to data type. Measures that differ significantly between
the two groups will be included as covariates in statis-
tical models comparing interventions. The distribution
of data will be analysed.
SPSS v23 will be used to investigate progression within
groups by regression analysis. The frequency that each
person achieves their activity goal, as set automatically
by the watch, will be explored within the intervention
groups at discharge from inpatient rehabilitation.
For outcome data, the linear mixed models (LMM)
procedure in SAS 9.4 will be used to determine the
mean changes in measures, as response variables, ac-
cording to two intervention regimes (intervention and
control) and three repeated measurements, using base-
line as a covariate. Distribution of the data will be
checked according to various methods of analysis, which
are employed at different stages of the study. The ana-
lysis of outcome, which will be based on LMM, assumes
a Gaussian distribution that can be checked and tested
by standard methods. However, we also note that LMM
is, in general, quite robust to violation of the distribu-
tional assumptions.
This model treats all factors as categorical, and so differ-
ent types of data can be used. Further and based on the dif-
ferences in least squares (marginal) means between the two
groups (intervention vs control), provided by LMM ana-
lysis, power, effect size (Cohen’s d) and their 95% non-
central confidence limits will be calculated. Analysis will be
used for each outcome measure. The “group” term is the
intervention group; the “time” term is the assessment time
point. The group-by-time interaction effect will reveal if
there is a greater change over time in one group compared
with the other.
For a sample size estimate, we used a conservative
estimate of the standardised effect size of change in phys-
ical activity levels from the initial assessment to discharge
from inpatient rehabilitation (i.e. the first phase of the
study) as our primary outcome of interest. Our pilot work
suggests an effect size of 0.12, and for alpha 0.05 and
power 0.95 for repeated measures with three measure-
ment points, we expect a sample of 182 to be adequately
powered. From pilot work we expect 10% to drop out, and
so we propose to recruit 200 patients.
Discussion
This study investigates whether setting personalized ac-
tivity goals derived from and coupled with personal and
early feedback on the amount of activity undertaken
throughout each day can enhance self-generated activity
levels, and whether any increase is associated with im-
proved functional outcomes. The study design integrates
the novel intervention into current practice which en-
sures that the results should be generally applicable. This
discussion will cover acknowledged weaknesses and limi-
tations, some arising from technological and financial
limitations and others, which follow on from new infor-
mation published after the protocol was finalized in July
2015. The discussion will also cover strengths and po-
tential outputs in terms of new knowledge.
Technological and financial limitations underlie many
of the weaknesses. The watch is only worn during the
five working days and only for nine working hours each
day. Ideally the watch would record activity and provide
feedback throughout the whole time a patient is awake,
including weekends and evenings. This limitation re-
flects constraints associated both with the watch and
with the setting. Data storage is limited, which means
that only 20% of the activity can be recorded. In
addition, download of data is required each day, which
requires a trained person, who is only available in work-
ing hours. Third, the watch needs charging each day,
again requiring a trained person. With advances in tech-
nology these constraints should be overcome.
The goal-setting algorithm designed to make allowance
for natural daily routines such as time of getting up, meal
times etc. is rigid, with fixed 2-hour slots. The increment
chosen - 5% - was arbitrary and further studies may be
needed to discover whether there is any better increment.
The increment may need to vary over the course of recov-
ery. In the early days and weeks quite large increases will
occur naturally, but over time the natural rate of change
drops and a stable increment might be more applicable
after the first 3 months. The visual feedback display seems
appropriate, but again there may be better designs; there
is always a compromise between detail and simplicity. Re-
cent research suggests that feedback coupled with goal
setting can be effective [11], and so an improvement in
technology coupled with increasing knowledge may make
the goal setting and feedback system more effective.
A third limiting factor arises from the funding and
timing of inpatient rehabilitation in Hefei, which starts
quite late after stroke and is limited to 2 or 3 weeks of
inpatient rehabilitation, limiting the time the interven-
tion can be applied. By the time a person is admitted,
they have already established a pattern of behaviour.
Also, it may take at least 1 week to become familiar with
the device and its purpose and, because changing behav-
iour takes time, the intervention may be too short to
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lead to any detectable difference between the groups. It
was not possible to provide the watch for use at home,
mainly for practical reasons (daily data downloads and
recharging). Ideally the intervention should be continued
over many weeks.
The research funding was limited. The research data
were collected by the ward doctors, who were specific-
ally trained and collected the clinical data as part of their
normal work. However, this limited the options of using
more fixed procedures, for example when checking
cognitive ability. This will not cause any bias, but may
slightly limit generalizability.
Last, it has been assumed that increasing general, non-
specific activity levels will lead to specific changes in
mobility and independence is activities. This assumption
is reasonable, but the strength of the relationship is un-
known and a much larger study may be needed to show
any actual benefit.
One strength is that, according to our calculations, the
study is adequately powered; we will recruit about 200
patients. Second, the study is embedded with daily
clinical routines in a busy hospital, such that if the
intervention is effective, it should be easy to continue
the intervention.
If this study does not show an effect, there will still be
worthwhile knowledge generated. The study will give an
estimate of variance in the measures used, which will
help in future power calculations. It will discover
whether a short episode of feedback on activity set
against goals might have an effect. Failure to find an
effect should not be taken as proving the intervention is
ineffective, given the limitations identified. The study
will give information about the feasibility of collecting
data in a trial set within a standard rehabilitation
programme in China (Additional file 1).
Trial status
At the time of original submission (20 February 2017) re-
cruitment in the trial had started and 88 patients had been
recruited. Recruitment ended with 160 patients on 16
June 2017 with final follow up on 16 September 2017.
Additional file
Additional file 1: SPIRIT 2013 Checklist: Recommended items to address
in a clinical trial protocol and related documents. (DOCX 118 kb)
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